3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
23
INDUSTRY
17
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
134
Urinary Bladder Neoplasms
47
Kidney Neoplasms
38
Carcinoma, Renal Cell
30
Wilms Tumor
29
Testicular Neoplasms
21
Urethral Neoplasms
16
Ovarian Neoplasms
15
Neoplasm Metastasis
14
Breast Neoplasms
14
Neuroblastoma
12
Sarcoma
11
Teratoma
10
Carcinoma, Non-Small-Cell Lung
9
Testicular Germ Cell Tumor
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Ovarian Germ Cell Cancer
8
Lung Neoplasms
8
Endodermal Sinus Tumor
8
Colorectal Neoplasms
7
Burkitt Lymphoma
7
Seminoma
6
Osteosarcoma
6
Neoplasms
6
Colonic Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Teratoma, Testicular
5
Recurrence
5
Pain
5
Head and Neck Neoplasms
5
Interventions
pembrolizumab
1
cabazitaxel
1
Standard of Care
1
Radiosurgery
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Prostate Cancer Metastatic
×
Genitourinary
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled
NCT05563558
2024-06-11
PEAPOD_FOS
Fundacion Oncosur
Phase 2
Recruiting
42 enrolled